المؤلفون: Kinamon T; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.; Oak Ridge Institute for Science and Education, United States Department of Energy, Oak Ridge, Tennessee, USA., Waack U; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Needles M; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Rubin D; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Collyar D; Patient Advocates in Research, Danville, California, USA., Doernberg SB; Department of Medicine, Division of Infectious Diseases, University of California San Francisco, San Francisco, California, USA., Evans SR; Biostatistics Center and Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington D.C., USA.; Antibacterial Resistance Leadership Group, Durham, North Carolina, USA., Hamasaki T; Biostatistics Center and Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington D.C., USA.; Antibacterial Resistance Leadership Group, Durham, North Carolina, USA., Holland TL; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Howard-Anderson J; Antibacterial Resistance Leadership Group, Durham, North Carolina, USA.; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA., Chambers H; Department of Medicine, Division of Infectious Diseases, University of California San Francisco, San Francisco, California, USA.; Antibacterial Resistance Leadership Group, Durham, North Carolina, USA., Fowler VG Jr; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.; Antibacterial Resistance Leadership Group, Durham, North Carolina, USA., Nambiar S; Antibacterial Resistance Leadership Group, Durham, North Carolina, USA.; Johnson and Johnson, Raritan, New Jersey, USA., Kim P; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Boucher HW; Antibacterial Resistance Leadership Group, Durham, North Carolina, USA.; Tufts University School of Medicine and Tufts Medicine, Boston, Massachusetts, USA., Gopinath R; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 19; Vol. 79 (1), pp. 60-69.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Pneumonia, Ventilator-Associated*/drug therapy , Pneumonia, Ventilator-Associated*/microbiology , Anti-Bacterial Agents*/therapeutic use , Pneumonia, Bacterial*/drug therapy , Pneumonia, Bacterial*/microbiology, Humans ; Male ; Healthcare-Associated Pneumonia/drug therapy ; Healthcare-Associated Pneumonia/microbiology ; Female ; United States ; Clinical Trials as Topic ; Cross Infection/drug therapy ; Treatment Outcome ; Middle Aged ; United States Food and Drug Administration ; Aged

المؤلفون: Quarton S; National Institute for Health Research Birmingham Biomedical Research Centre, Birmingham, United Kingdom.; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom., Livesey A; National Institute for Health Research Welcome Trust Clinical Research Facility, University Hospitals Birmingham, Birmingham, United Kingdom., Jeff C; National Institute for Health Research Birmingham Biomedical Research Centre, Birmingham, United Kingdom., Hatton C; National Institute for Health Research Midlands Patient Safety Research Collaboration, University of Birmingham, Birmingham, United Kingdom., Scott A; National Institute for Health Research Birmingham Biomedical Research Centre, Birmingham, United Kingdom., Parekh D; National Institute for Health Research Birmingham Biomedical Research Centre, Birmingham, United Kingdom., Thickett D; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom., McNally A; National Institute for Health Research Birmingham Biomedical Research Centre, Birmingham, United Kingdom., Sapey E; National Institute for Health Research Birmingham Biomedical Research Centre, Birmingham, United Kingdom.; National Institute for Health Research Midlands Patient Safety Research Collaboration, University of Birmingham, Birmingham, United Kingdom.; National Institute for Health Research Midlands Applied Research Collaborative, University of Birmingham, Birmingham, United Kingdom.

المصدر: JMIR research protocols [JMIR Res Protoc] 2024 Sep 18; Vol. 13, pp. e57334. Date of Electronic Publication: 2024 Sep 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Internet ISSN: 1929-0748 (Electronic) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: MEDLINE

مواضيع طبية MeSH: Metagenomics*/methods , Pneumonia*/diagnosis , Pneumonia*/microbiology, Humans ; Systematic Reviews as Topic ; High-Throughput Nucleotide Sequencing/methods ; Pneumonia, Ventilator-Associated/diagnosis ; Pneumonia, Ventilator-Associated/microbiology ; Bronchoalveolar Lavage Fluid/microbiology

عنوان ترانسليتريتد: Nosokomiale Pneumonie.

المؤلفون: Ewig S; Thoraxzentrum Ruhrgebiet, Kliniken für Pneumologie und Infektiologie, EVK Herne und Augusta-Krankenhaus Bochum, Hordeler Straße 7-9, 44651, Herne, Deutschland. s.ewig@evk-herne.de.

المصدر: Die Anaesthesiologie [Anaesthesiologie] 2024 Sep; Vol. 73 (9), pp. 630-644.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Medizin Country of Publication: Germany NLM ID: 9918384886806676 Publication Model: Print Cited Medium: Internet ISSN: 2731-6866 (Electronic) Linking ISSN: 27316858 NLM ISO Abbreviation: Anaesthesiologie Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Bacterial Agents*/therapeutic use , Healthcare-Associated Pneumonia*/microbiology , Healthcare-Associated Pneumonia*/diagnosis , Healthcare-Associated Pneumonia*/epidemiology, Humans ; Pneumonia, Ventilator-Associated/diagnosis ; Pneumonia, Ventilator-Associated/microbiology ; Pneumonia, Ventilator-Associated/drug therapy ; Cross Infection/microbiology ; Cross Infection/diagnosis ; Cross Infection/drug therapy ; Drug Resistance, Multiple, Bacterial

المؤلفون: Komiya K; Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan; Research Center for Global and Local Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan. Electronic address: komiyakh1@oita-u.ac.jp., Yamatani I; Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan; Department of Mycobacterium Reference and Research, the Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan. Electronic address: kaisyakuji-i@oita-u.ac.jp., Kadota JI; Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan. Electronic address: kadota@oita-u.ac.jp.

المصدر: Respiratory investigation [Respir Investig] 2024 Jul; Vol. 62 (4), pp. 710-716. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-5353 (Electronic) Linking ISSN: 22125345 NLM ISO Abbreviation: Respir Investig Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Bacterial Agents*/therapeutic use , Pneumonia, Aspiration*/drug therapy , Pneumonia, Aspiration*/microbiology , Pneumonia, Aspiration*/etiology, Humans ; Aged ; Drug Resistance, Bacterial ; Risk ; Longevity ; Aged, 80 and over ; Pneumonia/drug therapy ; Pneumonia/microbiology ; Hospital Mortality ; Methicillin-Resistant Staphylococcus aureus/drug effects

عنوان ترانسليتريتد: 10 Kernaussagen zur S3-Leitlinie „Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie“.

المؤلفون: Rademacher J; Klinik für Pneumologie und Infektiologie, Medizinische Hochschule Hannover, Hannover, Deutschland. rademacher.jessica@mh-hannover.de., Kluge S; Klinik für Intensivmedizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.

المصدر: Medizinische Klinik, Intensivmedizin und Notfallmedizin [Med Klin Intensivmed Notfmed] 2024 Sep; Vol. 119 (6), pp. 502-505. Date of Electronic Publication: 2024 Jul 10.

نوع المنشور: Journal Article; Practice Guideline; Review

بيانات الدورية: Publisher: Springer Medizin Country of Publication: Germany NLM ID: 101575086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2193-6226 (Electronic) Linking ISSN: 21936218 NLM ISO Abbreviation: Med Klin Intensivmed Notfmed Subsets: MEDLINE

مواضيع طبية MeSH: Healthcare-Associated Pneumonia*/diagnosis , Healthcare-Associated Pneumonia*/epidemiology , Healthcare-Associated Pneumonia*/therapy, Humans ; Germany ; Adult ; Anti-Bacterial Agents/therapeutic use ; Cross-Sectional Studies ; Cross Infection/epidemiology ; Cross Infection/diagnosis ; Cross Infection/prevention & control ; Risk Factors ; Pneumonia, Bacterial/diagnosis ; Pneumonia, Bacterial/epidemiology ; Intensive Care Units

المؤلفون: McCravy M; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA matthew.mccravy@duke.edu., O'Grady N; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Khan K; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Betancourt-Quiroz M; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Zaas AK; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Treece AE; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Yang Z; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Que L; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Henao R; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA., Suchindran S; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Ginsburg GS; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Woods CW; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., McClain MT; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Tsalik EL; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

المصدر: BMJ open respiratory research [BMJ Open Respir Res] 2024 Aug 03; Vol. 11 (1). Date of Electronic Publication: 2024 Aug 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd & British Thoracic Society Country of Publication: England NLM ID: 101638061 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4439 (Electronic) Linking ISSN: 20524439 NLM ISO Abbreviation: BMJ Open Respir Res Subsets: MEDLINE

مواضيع طبية MeSH: Streptococcus pneumoniae*/genetics , Streptococcus pneumoniae*/isolation & purification , Pneumonia, Mycoplasma*/diagnosis , Mycoplasma pneumoniae*/genetics , Mycoplasma pneumoniae*/isolation & purification , Disease Models, Animal*, Animals ; Humans ; Mice ; Female ; Pneumonia, Pneumococcal/microbiology ; Orthomyxoviridae Infections/immunology ; ROC Curve ; Gene Expression Profiling ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/immunology ; Mice, Inbred C57BL ; Pneumonia, Bacterial/microbiology ; Pneumonia, Bacterial/diagnosis ; Host-Pathogen Interactions

المؤلفون: Huang Y; Department of Emergency, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China., Guo H; Department of Emergency, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China., Li Y; Department of Emergency, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

المصدر: Medicine [Medicine (Baltimore)] 2024 Sep 06; Vol. 103 (36), pp. e39571.

نوع المنشور: Journal Article; Case Reports

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

مواضيع طبية MeSH: Streptococcus pneumoniae*/isolation & purification , Streptococcus pneumoniae*/immunology , Bronchoalveolar Lavage Fluid*/microbiology , Pneumonia, Pneumococcal*/diagnosis , Pneumonia, Pneumococcal*/microbiology , Antigens, Bacterial*/analysis , Antigens, Bacterial*/immunology, Humans ; Male ; Aged ; Pneumonia, Necrotizing/diagnosis ; Pneumonia, Necrotizing/microbiology ; Anti-Bacterial Agents/therapeutic use ; Tomography, X-Ray Computed

المؤلفون: Todkill D; United Kingdom Health Security Agency (UKHSA), London, United Kingdom.; Warwick Medical School, Coventry, United Kingdom., Lamagni T; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Pebody R; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Ramsay M; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Woolham D; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Demirjian A; United Kingdom Health Security Agency (UKHSA), London, United Kingdom.; Evelina London Children's Hospital, London, United Kingdom., Salzmann A; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Chand M; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Hughes HE; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Bennett C; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Hope R; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Watson CH; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Brown CS; United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Elliot AJ; United Kingdom Health Security Agency (UKHSA), London, United Kingdom.

المصدر: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Aug; Vol. 29 (32).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE

مواضيع طبية MeSH: Pneumonia*/epidemiology , Mycoplasma pneumoniae*/isolation & purification , Emergency Service, Hospital*/statistics & numerical data, Humans ; Child ; England/epidemiology ; Child, Preschool ; Adolescent ; Incidence ; Male ; Female ; Prevalence ; Pneumonia, Mycoplasma/epidemiology ; Pneumonia, Mycoplasma/diagnosis ; Seasons ; Population Surveillance

المؤلفون: Nobre C; Department of Intensive Care (ICU4), Hospital de São Francisco Xavier Centro Hospitalar Lisboa Ocidental, Estrada do Forte do Alto Duque, 1449-0054 Lisbon, Portugal. Electronic address: carlanobre.med@gmail.com., Moniz P; Department of Intensive Care (ICU4), Hospital de São Francisco Xavier Centro Hospitalar Lisboa Ocidental, Estrada do Forte do Alto Duque, 1449-0054 Lisbon, Portugal., Faria NA; Laboratory of Bacterial Evolution and Molecular Epidemiology, Instituto de Tecnologia Química e Biológica António Xavier (ITQB-NOVA), Universidade Nova de Lisboa, Avenida da República, 2780-157 Oeiras, Portugal; Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica António Xavier (ITQB-NOVA), Universidade Nova de Lisboa, Avenida da República, 2780-157 Oeiras, Portugal.

المصدر: Pulmonology [Pulmonology] 2024 Jul-Aug; Vol. 30 (4), pp. 397-400. Date of Electronic Publication: 2023 Nov 23.

نوع المنشور: Case Reports; Letter

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 101723786 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2531-0437 (Electronic) Linking ISSN: 25310429 NLM ISO Abbreviation: Pulmonology Subsets: MEDLINE

مواضيع طبية MeSH: Staphylococcus aureus* , Pneumonia, Necrotizing*/diagnosis , Pneumonia, Necrotizing*/microbiology , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/pharmacology, Humans ; Pneumonia, Staphylococcal/microbiology ; Pneumonia, Staphylococcal/drug therapy ; Pneumonia, Staphylococcal/diagnosis ; Male ; Female ; Middle Aged ; Microbial Sensitivity Tests

المؤلفون: Pirracchio R; Department of Anesthesia and Perioperative Medicine, University of California San Francisco.; Associate Editor, JAMA., Venkatesh B; The George Institute for Global Health, University of New South Wales Sydney, Australia.; Gold Coast University Hospital, Southport, Queensland, Australia., Legrand M; Department of Anesthesia and Perioperative Medicine, University of California San Francisco.

المصدر: JAMA [JAMA] 2024 Jul 23; Vol. 332 (4), pp. 318-328.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Critical Illness* , Community-Acquired Infections*/drug therapy , Pneumonia, Pneumocystis*/drug therapy, Humans ; Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/adverse effects ; Adrenal Cortex Hormones/therapeutic use ; Adult ; Hydrocortisone/therapeutic use ; Hydrocortisone/administration & dosage ; COVID-19 Drug Treatment ; Dexamethasone/administration & dosage ; Dexamethasone/therapeutic use ; Dexamethasone/adverse effects ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/mortality ; Influenza, Human/drug therapy ; Influenza, Human/mortality ; Glucocorticoids/administration & dosage ; Glucocorticoids/therapeutic use ; Respiratory Distress Syndrome/drug therapy ; Respiratory Distress Syndrome/mortality